Cargando…
Prophylactic Antitumor Effect of Mixed Heat Shock Proteins/Peptides in Mouse Sarcoma
BACKGROUND: To develop a vaccine-based immunotherapy for sarcoma, we evaluated a mixture of heat shock proteins (mHSPs) as a vaccine for sarcoma treatment in a mouse model. Heat shock protein/peptides (HSP/Ps) are autoimmune factors that can induce both adaptive and innate immune responses; HSP/Ps i...
Autores principales: | Wang, Yu, Liu, Shu-Yun, Yuan, Mei, Tang, Yu, Guo, Quan-Yi, Cui, Xue-Mei, Sui, Xiang, Peng, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717971/ https://www.ncbi.nlm.nih.gov/pubmed/26265619 http://dx.doi.org/10.4103/0366-6999.162516 |
Ejemplares similares
-
Antitumor activity of mixed heat shock protein/peptide vaccine and cyclophosphamide plus interleukin-12 in mice sarcoma
por: Guo, Quan-Yi, et al.
Publicado: (2011) -
Heat shock drives genomic instability and phenotypic variations in yeast
por: Shen, Li, et al.
Publicado: (2020) -
X66, a novel N-terminal heat shock protein 90 inhibitor, exerts antitumor effects without induction of heat shock response
por: Zhao, Zhixin, et al.
Publicado: (2016) -
Heat shock protein 70 downregulation inhibits proliferation, migration and tumorigenicity in hepatocellular carcinoma cells
por: Xiong, Ju, et al.
Publicado: (2017) -
Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial
por: Shimizu, Yasuhiro, et al.
Publicado: (2019)